U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C24H31ClO7
Molecular Weight 466.952
Optical Activity UNSPECIFIED
Defined Stereocenters 7 / 7
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of LOTEPREDNOL ETABONATE

SMILES

[H][C@@]12CC[C@](OC(=O)OCC)(C(=O)OCCl)[C@@]1(C)C[C@H](O)[C@@]3([H])[C@@]2([H])CCC4=CC(=O)C=C[C@]34C

InChI

InChIKey=DMKSVUSAATWOCU-HROMYWEYSA-N
InChI=1S/C24H31ClO7/c1-4-30-21(29)32-24(20(28)31-13-25)10-8-17-16-6-5-14-11-15(26)7-9-22(14,2)19(16)18(27)12-23(17,24)3/h7,9,11,16-19,27H,4-6,8,10,12-13H2,1-3H3/t16-,17-,18-,19+,22-,23-,24-/m0/s1

HIDE SMILES / InChI

Molecular Formula C24H31ClO7
Molecular Weight 466.952
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 7 / 7
E/Z Centers 0
Optical Activity UNSPECIFIED

Approval Year

Cmax

Cmax

ValueDoseCo-administeredAnalytePopulation
621 ng/mL
0.5 μg single, intraocular
dose: 0.5 μg
route of administration: Intraocular
experiment type: SINGLE
co-administered:
LOTEPREDNOL cornea
Oryctolagus cuniculus
population: HEALTHY
age: ADULT
sex: MALE
food status: UNKNOWN
AUC

AUC

ValueDoseCo-administeredAnalytePopulation
1130 ng × h/mL
0.5 μg single, intraocular
dose: 0.5 μg
route of administration: Intraocular
experiment type: SINGLE
co-administered:
LOTEPREDNOL cornea
Oryctolagus cuniculus
population: HEALTHY
age: ADULT
sex: MALE
food status: UNKNOWN
T1/2

T1/2

ValueDoseCo-administeredAnalytePopulation
3.75 h
0.5 μg single, intraocular
dose: 0.5 μg
route of administration: Intraocular
experiment type: SINGLE
co-administered:
LOTEPREDNOL cornea
Oryctolagus cuniculus
population: HEALTHY
age: ADULT
sex: MALE
food status: UNKNOWN
Funbound

Funbound

ValueDoseCo-administeredAnalytePopulation
2%
LOTEPREDNOL plasma
Homo sapiens
population: UNKNOWN
age: UNKNOWN
sex: UNKNOWN
food status: UNKNOWN
Doses

Doses

DosePopulationAdverse events​
1 drop 4 times / day multiple, topical
Recommended
Dose: 1 drop, 4 times / day
Route: topical
Route: multiple
Dose: 1 drop, 4 times / day
Sources: Page: p.461
unhealthy, 3.4 ± 1.1
n = 109
Health Status: unhealthy
Condition: Giant papillary conjunctivitis
Age Group: 3.4 ± 1.1
Sex: M+F
Population Size: 109
Sources: Page: p.461
Disc. AE: Intraocular pressure increased...
AEs leading to
discontinuation/dose reduction:
Intraocular pressure increased (2.8%)
Sources: Page: p.461
AEs

AEs

AESignificanceDosePopulation
Intraocular pressure increased 2.8%
Disc. AE
1 drop 4 times / day multiple, topical
Recommended
Dose: 1 drop, 4 times / day
Route: topical
Route: multiple
Dose: 1 drop, 4 times / day
Sources: Page: p.461
unhealthy, 3.4 ± 1.1
n = 109
Health Status: unhealthy
Condition: Giant papillary conjunctivitis
Age Group: 3.4 ± 1.1
Sex: M+F
Population Size: 109
Sources: Page: p.461
Substance Class Chemical
Created
by admin
on Wed Jul 05 23:15:19 UTC 2023
Edited
by admin
on Wed Jul 05 23:15:19 UTC 2023
Record UNII
YEH1EZ96K6
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
LOTEPREDNOL ETABONATE
JAN   MART.   MI   ORANGE BOOK   USAN   VANDF   WHO-DD  
USAN  
Official Name English
ZYLET COMPONENT LOTEPREDNOL ETABONATE
Common Name English
Chloromethyl 11β,17-dihydroxy-3-oxoandrosta-1,4-diene-17β-carboxylate, 17-(ethyl carbonate)
Common Name English
P-5604
Code English
LOTEPREDNOL ETABONATE [VANDF]
Common Name English
LOTEPREDNOL ETABONATE [USAN]
Common Name English
CDDD5604
Code English
HGP-1
Code English
Loteprednol etabonate [WHO-DD]
Common Name English
EYSUVIS
Brand Name English
ALREX
Brand Name English
LOTEPREDNOL ETABONATE [MART.]
Common Name English
ANDROSTA-1,4-DIENE-17-CARBOXYLIC ACID, 17-((ETHOXYCARBONYL)OXY)-11-HYDROXY-3-OXO-, CHLOROMETHYL ESTER, (11.BETA.,17.ALPHA.)-
Systematic Name English
LOTEPREDNOL ETABONATE [JAN]
Common Name English
INVELTYS
Brand Name English
CDDD-5604
Code English
LOTEMAX
Brand Name English
KPI-121
Code English
LOTEPREDNOL ETABONATE [MI]
Common Name English
LOTEPREDNOL ETABONATE COMPONENT OF ZYLET
Common Name English
LOTEPREDNOL ETABONATE [ORANGE BOOK]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C521
Created by admin on Wed Jul 05 23:15:19 UTC 2023 , Edited by admin on Wed Jul 05 23:15:19 UTC 2023
Code System Code Type Description
EPA CompTox
DTXSID2046468
Created by admin on Wed Jul 05 23:15:19 UTC 2023 , Edited by admin on Wed Jul 05 23:15:19 UTC 2023
PRIMARY
FDA UNII
YEH1EZ96K6
Created by admin on Wed Jul 05 23:15:19 UTC 2023 , Edited by admin on Wed Jul 05 23:15:19 UTC 2023
PRIMARY
DAILYMED
YEH1EZ96K6
Created by admin on Wed Jul 05 23:15:19 UTC 2023 , Edited by admin on Wed Jul 05 23:15:19 UTC 2023
PRIMARY
DRUG BANK
DB00873
Created by admin on Wed Jul 05 23:15:19 UTC 2023 , Edited by admin on Wed Jul 05 23:15:19 UTC 2023
PRIMARY
RXCUI
52177
Created by admin on Wed Jul 05 23:15:19 UTC 2023 , Edited by admin on Wed Jul 05 23:15:19 UTC 2023
PRIMARY RxNorm
MERCK INDEX
M6912
Created by admin on Wed Jul 05 23:15:19 UTC 2023 , Edited by admin on Wed Jul 05 23:15:19 UTC 2023
PRIMARY Merck Index
SMS_ID
100000076769
Created by admin on Wed Jul 05 23:15:19 UTC 2023 , Edited by admin on Wed Jul 05 23:15:19 UTC 2023
PRIMARY
IUPHAR
7085
Created by admin on Wed Jul 05 23:15:19 UTC 2023 , Edited by admin on Wed Jul 05 23:15:19 UTC 2023
PRIMARY
USAN
BB-79
Created by admin on Wed Jul 05 23:15:19 UTC 2023 , Edited by admin on Wed Jul 05 23:15:19 UTC 2023
PRIMARY
EVMPD
SUB14390MIG
Created by admin on Wed Jul 05 23:15:19 UTC 2023 , Edited by admin on Wed Jul 05 23:15:19 UTC 2023
PRIMARY
ChEMBL
CHEMBL1200865
Created by admin on Wed Jul 05 23:15:19 UTC 2023 , Edited by admin on Wed Jul 05 23:15:19 UTC 2023
PRIMARY
PUBCHEM
444025
Created by admin on Wed Jul 05 23:15:19 UTC 2023 , Edited by admin on Wed Jul 05 23:15:19 UTC 2023
PRIMARY
CAS
82034-46-6
Created by admin on Wed Jul 05 23:15:19 UTC 2023 , Edited by admin on Wed Jul 05 23:15:19 UTC 2023
PRIMARY
NCI_THESAURUS
C47589
Created by admin on Wed Jul 05 23:15:19 UTC 2023 , Edited by admin on Wed Jul 05 23:15:19 UTC 2023
PRIMARY
DRUG CENTRAL
1611
Created by admin on Wed Jul 05 23:15:19 UTC 2023 , Edited by admin on Wed Jul 05 23:15:19 UTC 2023
PRIMARY
Related Record Type Details
TARGET -> AGONIST
Related Record Type Details
ACTIVE MOIETY